MedTrace Logo

Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)

NCT02555072 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4761

Last updated 2023-06-13

No results posted yet for this study

Summary

The study main objective is to assess the immune status of children and adults who have never vaccinated, they will receive the first dose of 17DD yellow fever vaccine provided by the study and will be monitored for 10 years. Depending on the results of the analyzed of the data, the period of monitoring may be extended.

Conditions

  • Yellow Fever Vaccine
  • Immunity

Interventions

BIOLOGICAL

yellow fever vaccine

yellow fever vaccination in naive individuals who leaves in a state where this type of vaccination is not recommendated

Sponsors & Collaborators

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

    lead OTHER

Principal Investigators

  • Eduardo Sergio S Sousa, MD · Universidade Federal da Paraíba

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
9 Months
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2026-06-30
Completion
2027-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02555072 on ClinicalTrials.gov